Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Trial of Intravenous Heme Arginate on HO-1 Expression and Oxidative Stress in the Human Heart
2013-000887-27Phase 2Completed
- Sponsor
- Medical University of Vienna
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of heme arginate in ischemia-reperfusion injury (IRI) and cardiac ischemia (2 arms), sponsored by Medical University of Vienna. Primary endpoints: Myocardial HO-1 induction and Postoperative biomarkers of myocardial injury and oxidative stress. Started Apr 2013; status: completed.
02
Drugs
heme arginate
03
Conditions
ischemia-reperfusion injury (IRI)cardiac ischemia
Beyond the preview
Go deeper on 2013-000887-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000887-27.